Clinical Trial Update: Complement and Graft-versus-host Disease [NA]

View source ↗

Summary

Clinical trial on the role of complement in graft-versus-host disease has completed in allogeneic transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graft-versus-host Disease

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Allografted With Myeloablative Conditioning | NA | Status: COMPLETED